Increase external collaborations to support drug discovery and development.	Reviewed existing internal sources of innovation and expert opinions. Identified key areas requiring objective planning and problem solving. Designed expert communities to support key areas requiring innovation and creativity. Devised operational plans for managing expert communities and how they connect to project teams.	New organisation structure involving collaborations with external experts and networks. Transparent systems to increase awareness and utilisation of both internal and external experts. Upgraded project management and steering processes that integrates external advisers.	Project teams who are proactive in maximising the use of both internal and external experts, leading to better drug discovery and development performance. New mentality and acceptance of external expert opinions by project teams and R&D management.